Contractor Notice: Loestrin 20 and 30 discontinued

Contractor Notice: Loestrin 20 and 30 discontinued

October 18, 2019

Galen Pharma have announced that following manufacturing issues with Loastrin 20 and 30, they will be discontinuing both products.

Loestrin 20 (norethisterone acetate 1mg, ethinylestradiol 0.02mg per tablet; PL 27827/0023)
Loestrin 30 (norethisterone acetate 1.5mg, ethinylestradiol 0.03mg per tablet; PL 27827/0024)

Galen say ‘despite endeavors to resolve issues experienced by our contracted manufacturer of our licensed products, Loestrin 20 and Loestrin 30, as well as our efforts to identify an alternative manufacturer, Galen wish to advise both products are being discontinued.’

For more information please contact Galen Pharma 



Posted in: ,

More Latest News >

CPCS Frequently Asked Questions

With the Community Pharmacist Consultation Service (CPCS) now bedding in, below you will find a selection of questions about the...

CPCS: CPD opportunities

As announced in the 5-year CPCF agreement, NHS England & NHS Improvement and Health Education England (HEE) will use funding...